{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:22:10Z","timestamp":1720646530025},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["U54GM104942","CA193878","CA016672"],"award-info":[{"award-number":["U54GM104942","CA193878","CA016672"]}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.cct.2016.11.002","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T14:18:23Z","timestamp":1478701103000},"page":"46-53","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A response-adaptive design of initial therapy for emergency department patients with heart failure"],"prefix":"10.1016","volume":"52","author":[{"given":"Sijin","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cct.2016.11.002_bb0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molonc.2015.02.011","article-title":"The brave new world of clinical cancer research: adaptive biomarker-driven trials integrating clinical practice with clinical research","volume":"9","author":"Berry","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cct.2016.11.002_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrclinonc.2011.165","article-title":"Adaptive clinical trials in oncology","volume":"8","author":"Berry","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cct.2016.11.002_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/sim.2247","article-title":"Continuous Bayesian adaptive randomization based on event times with covariates","volume":"25","author":"Cheung","year":"2006","journal-title":"Stat. Med."},{"key":"10.1016\/j.cct.2016.11.002_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1198\/016214503000000576","article-title":"Optimality, variability, power: evaluating response-adaptive randomization procedures for treatment comparisons","volume":"98","author":"Hu","year":"2003","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.cct.2016.11.002_bb0025","series-title":"The Theory of Response-adaptive Randomization in Clinical Trials","author":"Hu","year":"2006"},{"key":"10.1016\/j.cct.2016.11.002_bb0030","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jspi.2005.08.011","article-title":"Asymptotically best response-adaptive randomization procedures","volume":"136","author":"Hu","year":"2006","journal-title":"J. Stat. Plann. Inference"},{"key":"10.1016\/j.cct.2016.11.002_bb0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1740774508091815","article-title":"Bayesian adaptive design for targeted therapy development in lung cancer - a step toward personalized medicine","volume":"5","author":"Zhou","year":"2008","journal-title":"Clin. Trials"},{"key":"10.1016\/j.cct.2016.11.002_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1214\/088342304000000044","article-title":"Bayesian statistics and the efficiency and ethics of clinical trials","volume":"19","author":"Berry","year":"2004","journal-title":"Stat. Sci."},{"key":"10.1016\/j.cct.2016.11.002_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1927","article-title":"Bayesian clinical trials","volume":"5","author":"Berry","year":"2006","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.cct.2016.11.002_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/biomet\/75.2.303","article-title":"Two-stage selection and testing designs for comparative clinical trials","volume":"75","author":"Thall","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.cct.2016.11.002_bb0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/biomet\/77.3.507","article-title":"Optimal two-stage screening designs for survival comparisons","volume":"77","author":"Schaid","year":"1990","journal-title":"Biometrika"},{"key":"10.1016\/j.cct.2016.11.002_bb0060","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1541-0420.2008.01175.x","article-title":"Adaptive randomization for multiarm comparative clinical trials based on joint efficacy\/toxicity outcomes","volume":"65","author":"Ji","year":"2009","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.cct.2016.11.002_bb0065","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics 2011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cct.2016.11.002_bb0070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cct.2016.11.002_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (adhere)","volume":"149","author":"Adams","year":"2005","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.cct.2016.11.002_bb0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"The Euroheart Failure survey programme \u2014 a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cct.2016.11.002_bb0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)","volume":"37","author":"Follath","year":"2011","journal-title":"Intensive Care Med."},{"issue":"14","key":"10.1016\/j.cct.2016.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archinte.167.14.1493","article-title":"Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"167","author":"Fonarow","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.cct.2016.11.002_bb0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The Euroheart Failure survey programme\u2013a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.cct.2016.11.002_bb0100","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"Euroheart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.cct.2016.11.002_bb0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jacc.2010.03.051","article-title":"National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities","volume":"56","author":"Peacock","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.cct.2016.11.002_bb0110","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/CIR.0b013e3181f9a223","article-title":"Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association","volume":"122","author":"Weintraub","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cct.2016.11.002_bb0115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/eurjhf\/hfq133","article-title":"International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes","volume":"12","author":"Collins","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.cct.2016.11.002_bb0120","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/CIRCULATIONAHA.109.192667","article-title":"Heart disease and stroke statistics\u20132010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"9100","key":"10.1016\/j.cct.2016.11.002_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.cct.2016.11.002_bb0130","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J. Heart Fail."},{"issue":"3","key":"10.1016\/j.cct.2016.11.002_bb0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","article-title":"The prognostic importance of different definitions of worsening renal function in congestive heart failure","volume":"8","author":"Gottlieb","year":"2002","journal-title":"J. Card. Fail."},{"issue":"1","key":"10.1016\/j.cct.2016.11.002_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/clpt.2009.68","article-title":"I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy","volume":"86","author":"Barker","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.cct.2016.11.002_bb0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cardfail.2010.02.001","article-title":"The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure","volume":"16","author":"Aronson","year":"2010","journal-title":"J. Card. Fail."},{"issue":"17","key":"10.1016\/j.cct.2016.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.cct.2016.11.002_bb0155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.annemergmed.2007.02.022","article-title":"Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis","volume":"50","author":"Levy","year":"2007","journal-title":"Ann. Emerg. Med."},{"issue":"9","key":"10.1016\/j.cct.2016.11.002_bb0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.11.002_bb0165","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ejca.2007.01.006","article-title":"Practical Bayesian adaptive randomization in clinical trials","volume":"43","author":"Thall","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cct.2016.11.002_bb0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.0006-341X.2002.00560.x","article-title":"Adaptive decision making in a lymphocyte infusion trial","volume":"58","author":"Thall","year":"2002","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2016.11.002_bb0175","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.0006-341X.2001.00909.x","article-title":"Optimal adaptive designs for binary response trials","volume":"57","author":"Rosenberger","year":"2001","journal-title":"Biometrics"},{"issue":"8","key":"10.1016\/j.cct.2016.11.002_bb0180","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/annonc\/mdv238","article-title":"Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials","volume":"26","author":"Thall","year":"2015","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.cct.2016.11.002_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/2159-8274.CD-10-0010","article-title":"The BATTLE trial: personalizing therapy for lung cancer","volume":"1","author":"Kim","year":"2011","journal-title":"Cancer discov."},{"issue":"17","key":"10.1016\/j.cct.2016.11.002_bb0190","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials","volume":"298","author":"McMurray","year":"2007","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.cct.2016.11.002_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O\u2019connor","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9860","key":"10.1016\/j.cct.2016.11.002_bb0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.cct.2016.11.002_bb0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardfail.2008.12.013","article-title":"The rationale for an acute heart failure syndromes clinical trials network","volume":"15","author":"Collins","year":"2009","journal-title":"J. card. fail."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416304219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416304219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T22:22:07Z","timestamp":1536272527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714416304219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":41,"alternative-id":["S1551714416304219"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2016.11.002","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A response-adaptive design of initial therapy for emergency department patients with heart failure","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}